8 products were found matching "Cay13539-%25"!

No results were found for the filter!
COVID-19 Research
E-64d
E-64d

Item number: Cay13533-25

E-64d is an irreversible, membrane-permeable inhibitor of lysosomal and cytosolic cysteine proteases and has diverse biological activities. It is a synthetic analog of E-64 (Cay-10007963) and prodrug form of E-64c (Cay-10007964) that inhibits calpain and the cysteine proteases cathepsins F, -K, -B, -H, and...
Keywords: Aloxistatin, E-64c ethyl ester, EP 453, EST, Loxistatin, NSC 694281,...
Application: Protease inhibitor
CAS 88321-09-9
MW: 342.4 D
From 66.00€ *
Review
(-)-Warfarin
(-)-Warfarin

Item number: Cay13531-25

(-)-Warfarin is a component of (±)-warfarin (Cay-13566). It is an anticoagulant that interferes with interconversion of vitamin K and vitamin K epoxide and the role of vitamin K in carboxylation of several clotting cascade proteins, inhibiting the initiation of clotting. In vivo, (-)-warfarin slows formation of the...
Keywords: (S)-Warfarin, 4-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-2-one
Application: Anti-coagulant
CAS 5543-57-7
MW: 308.3 D
From 94.00€ *
Review
BQCA
BQCA

Item number: Cay15393-25

BQCA is a highly selective positive allosteric modulator of the M1 muscarinic acetylcholine receptor (mAChR), as it dose-dependently reduces the concentration of acetylcholine required to activate the M1 receptor. The effective range for potentiation of M1 in cells by BQCA is 0.1 to 100 µM with an inflection point...
Keywords: 1,4-dihydro-1-[(4-methoxyphenyl)methyl]-4-oxo-3-quinolinecarboxylic acid
Application: Highly selective positive allosteric muscarinic acetylcholine receptor M1 modulator
CAS 338747-41-4
MW: 309.3 D
From 84.00€ *
Review
Imatinib (mesylate)
Imatinib (mesylate)

Item number: Cay13139-25

Imatinib is an inhibitor of the receptor tyrosine kinases c-Abl, Bcr-Abl, PDGFR, and c-Kit. It inhibits ligand-stimulated autophosphorylation of PDGFR and c-Kit (IC50s = ~0.3 and ~0.1 µM, respectively). Imatinib inhibits the proliferation of Bcr-Abl-dependent R10(-) cells (IC50s = ~35-40 nM) and HMC-1 cells...
Keywords: CGP57148B, STI-571,...
Application: Tyrosine kinase inhibitor
CAS 220127-57-1
MW: 589.7 D
From 40.00€ *
Review
Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic Acid
Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaen...

Item number: Cay10539-50

Very long chain polyunsaturated fatty acids (VLCPUFAs) are important components of ceramides and sphingomyelin and are present in retina, sperm, and brain. Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic acid is a C34:6 VLCPUFA whose specific biological actions are largely unknown. This VLCPUFA, along...
Keywords: 16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoic acid
Application: Bioactive Lipid Assays
CAS 105528-06-1
MW: 496.8 D
From 125.00€ *
Review
RD162
RD162

Item number: Cay13039-25

RD162 is a second-generation androgen receptor (AR) antagonist. It inhibits binding of 18F-FDHT to AR in human prostate cancer cells with an IC50 value of 30.9 nM. RD162 completely suppresses VCaP cell proliferation at 1 µM and induces apoptosis of VCaP cells at 10 µM. RD162 is bioavailable and reduces LNCaP/AR...
Keywords: 4-[7-[4-cyano-3-(trifluoromethyl)phenyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl-benzamide
Application: Androgen receptor antagonist
CAS 915087-27-3
MW: 476.4 D
From 46.00€ *
Review
SQ 22,536
SQ 22,536

Item number: Cay13339-25

SQ 22,536 is an inhibitor of adenylyl cyclase with an IC50 value of 13 µM for inhibition of prostaglandin E1-stimulated increase in cAMP in intact platelets. It has been used to evaluate adenylyl cyclase activity during iloprost-induced vasorelaxation of isolated pulmonary veins or aorta in several research...
Keywords: NSC 53339, 9-(tetrahydro-2-furanyl)-9H-purin-6-amine
Application: Adenylyl cyclase inhibitor
CAS 17318-31-9
MW: 205.2 D
From 84.00€ *
Review
WZ811
WZ811

Item number: Cay13639-25

The CXC chemokine receptor-4 (CXCR4) is a G protein-coupled receptor that is specific for stromal cell-derived factor-1 (SDF-1/ CXCL12). Activation of CXCR4 promotes homing of hematopoietic stem cells, chemotaxis and quiescence of lymphocytes, and growth and metastasis of certain cancer cell types. Moreover, CXCR4...
Keywords: N1,N4-di-2-pyridinyl-1,4-benzenedimethanamine
Application: CXCR4 antagonist
CAS 55778-02-4
MW: 290.4 D
From 26.00€ *
Review